|
NUP188 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.902100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.217990E-02 |
| Normal-vs-Stage2 |
4.984400E-01 |
| Normal-vs-Stage3 |
4.002400E-01 |
| Normal-vs-Stage4 |
3.143800E-02 |
| Stage1-vs-Stage2 |
4.144800E-01 |
| Stage1-vs-Stage3 |
4.090400E-01 |
| Stage1-vs-Stage4 |
6.972600E-01 |
| Stage2-vs-Stage3 |
9.281000E-01 |
| Stage2-vs-Stage4 |
2.898600E-01 |
| Stage3-vs-Stage4 |
3.334200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.146200E-02 |
| Normal-vs-AfricanAmerican |
7.130100E-02 |
| Normal-vs-Asian |
3.684500E-03 |
| Caucasian-vs-AfricanAmerican |
7.485000E-01 |
| Caucasian-vs-Asian |
2.024000E-01 |
| AfricanAmerican-vs-Asian |
2.282600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.899100E-03 |
| Normal-vs-Female |
9.039200E-01 |
| Male-vs-Female |
4.255900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.239620E-01 |
| Normal-vs-Extreme_Weight |
4.318500E-03 |
| Normal-vs-Obese |
5.464400E-01 |
| Normal-vs-Extreme_Obese |
2.014400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.571400E-01 |
| Normal_Weight-vs-Obese |
4.152800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.682200E-01 |
| Extreme_Weight-vs-Obese |
1.100570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.923800E-01 |
| Obese-vs-Extreme_Obese |
1.296980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.730400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.552800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.560100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.496400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.530000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.273600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.738200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.046100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.596000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.070820E-01 |
| Normal-VS-Type2 PRCC |
4.236000E-02 |
| Normal-VS-KIRP CIMP |
6.669200E-01 |
| Normal-VS-Unclassified PRCC |
7.940600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.401400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.319000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.000200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.897580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.956820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.478400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.006000E-02 |
| Normal-vs-N1 |
5.619400E-01 |
| Normal-vs-N2 |
8.871400E-01 |
| N0-vs-N1 |
2.477000E-01 |
| N0-vs-N2 |
3.141800E-01 |
| N1-vs-N2 |
7.468400E-01 |
|
|
